To create a global network that works with local partners to support health care workers, policy makers, researchers and people who use drugs to increase hepatitis C prevention and care.


1. Support and facilitate scientific exchange and dissemination of knowledge

2. Educate health professionals, researchers, community organisations, people who use drugs and policy makers on hepatitis C prevention, screening, linkage to care, and treatment

3. Collaborate with other societies, government organisations, professional associations, community members, institutions and individuals to advocate for hepatitis C prevention and care among people who use drugs.


All people have access to high quality, compassionate, and equitable health care.


INTEGRITY We act with trustworthiness, honesty and fairness.

EXCELLENCE & INNOVATION We encourage new ways of thinking and strive to reflect best practice in all we do.

RESPECT We value the input of all of those working in or affected by hepatitis and/or drug use. We believe that better decisions are made when all perspectives are shared and respected.

COLLABORATION We value collaboration with other agencies and partners in our community. We understand that we can accomplish more when we work together to develop complimentary initiatives and resources.


Based in Switzerland, the organization was conceptualized by Philip Bruggman, Markus Backmund and Geert Robays who organised the first INHSU symposium in Zurich, Switzerland, in 2009.

This was followed by another meeting in Brussels, Belgium, in 2011, Munich, Germany, in 2013 and Sydney, Australia, in 2015. In 2016, INHSU moved to an annual symposium to keep pace with the rapid development of new therapies and the 2016 symposium was held in Oslo, Norway.

In 2015, Jason Grebely was nominated as President of INHSU and the Board of Directors was broadened to include representation from Australia, North America and other areas of Europe. At this time, INHSU also established strategic goals and instituted membership, allowing the wider community working in or affected by hepatitis C and drug use to help shape the organisation.